1. Combination of gefitinib and olaparib versus gefitinib alone in EGFR mutant non-small-cell lung cancer (NSCLC): A multicenter, randomized phase II study (GOAL). (December 2020) Authors: Garcia-Campelo, Rosario; Arrieta, Oscar; Massuti, Bartomeu; Rodriguez-Abreu, Delvys; Granados, Ana Laura Ortega; Majem, Margarita; Vicente, David; Lianes, Pilar; Bosch-Barrera, Joaquim; Insa, Amelia; Dómine, Manuel; Reguart, Noemí; Guirado, María; Sala, María Ángeles; Vázquez-Estevez, Sergio; Car... Journal: Lung cancer Issue: Volume 150(2020) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗